NCT05381324View on ClinicalTrials.gov

Fistula-associated Anal Adenocarcinoma

CompletedOBSERVATIONAL

Enrollment

1,004

Participants

Timeline

Start Date

January 1, 1999

Primary Completion Date

December 31, 2019

Study Completion Date

May 1, 2022

Conditions

Rectal Cancer

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT05381324 - Fistula-associated Anal Adenocarcinoma | Biotech Hunter | Biotech Hunter